Monte Rosa Therapeutics(GLUE)
BOSTON, MA
Biotechnology1 H-1B visas (FY2023)Focus: Small molecule cancer drugs that modulate protein degradation pathways
Monte Rosa Therapeutics is a life sciences company focused on Small molecule cancer drugs that modulate protein degradation pathways.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
MRT-6160
Healthy VolunteersClinical Trials (1)
NCT06597799First-in-human Study of MRT-6160 in Healthy Subjects
Phase 1MRT-8102
Healthy VolunteersClinical Trials (1)
NCT07119125A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP
Phase 1Oral MRT-2359
NSCLCClinical Trials (1)
NCT05546268Study of Oral MRT-2359 in Selected Cancer Patients
Phase 1/2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2024
Portfolio: 3 clinical trials
H-1B (2023): 1 approval
SEC Filings: 2 available
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub